Antihypertensive and antioxidant effects of a hydroalcoholic extract obtained from aerial parts of Otostegia persica (Burm.) Boiss

Research in Pharmaceutical Sciences

Volumn 10, Issue 3, 2015, Pages 192-199

  Safaeian, L ^a   Ghasemi Dehkordi, N ^a   Javanmard, Sh Haghjoo ^b   Namvar, H ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant activity; Hypertension; Otostegia persica

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DEXAMETHASONE; FERRIC SULFATE; HYDROGEN PEROXIDE; OTOSTEGIA PERSICA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; HYPERTENSION; LAMIACEAE; MALE; NONHUMAN; ORGAN WEIGHT; OTOSTEGIA PERSICA; RAT; SYSTOLIC BLOOD PRESSURE; THYMUS; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

EID: 84936773884     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92:29-41.
2. Ayub MY, Norazmir MN, Mamot S, Jeeven K, Hadijah H. Anti-hypertensive effect of pink guava (Psidium guajava) puree on spontaneous hypertensive rats. Int Food Res J. 2010;17:89-96.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
4. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens. 2005;14:125-131.
5. Takahashi H. Sympathetic hyperactivity in hypertension. Nihon Rinsho. 2008;66:1495-1502.
6. Shreenivas S, Oparil S. The role of endothelin-1 in human hypertension. Clin Hemorheol Microcirc. 2007;37:157-178.
7. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139:761-776.
8. Evans RG, Kett MM, Shweta A, Fitzgerald SM, Denton KM, Eppel GA, et al. New physiological target within the kidney for antihypertensive therapy. Drug Des Rev. 2005;2:167-178.
9. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5:30-40.
10. Ayatollahi SA, Kobarfard F, Asgarpanah J, Rahmati Roodsari M, Fanai Gh, Iqbal Choudhary M. Diterpenoids of Otostegia persica (Burm.) Boiss. DARU J Pharm Sci. 2009;17:290-293.
11. Andemariam SW. Legislative regulation of traditional medicinal knowledge in eritrea vis-à-vis eritrea's commitments under the convention on biological diversity: issues and alternatives. Law Environ Dev J. 2010;6:130-166.
12. Chaudhary MA, Ahmed D, Khan SR. A study of Ballota limbata as an alternative medicine for eye diseases. Ethnobot Leaflets. 2009;13:1088-1095.
13. Asghari G, Nourallahi H, Havaie SA, Issa L. Antimicrobial activity of Otostegia persica Boiss extracts. Res Pharm Sci. 2006;1:53-58.
14. Sadeghi Z, Akaberi M, Valizadeh J. Otostegia persica (Lamiaceae): A review on its ethnopharmacology, phytochemistry, and pharmacology. Avicenna J Phytomed. 2014;4:79-88.
15. Yassa N, Sharififar F, Shafiee A. Otostegia persica as a source of natural antioxidants. Pharm Biol. 2005;43:33-38.
16. Tofighi Z, Alipour F, Yassa N, Hadjiakhoondi A, Hadavinia H, Goodarzy S, et al. Chemical composition and antioxidant activity of Otostegia persica essential oil from Iran. Int J Essen Oil Ther. 2009;3:45-48.
17. Nateghpoura M, Farivara L, Sourib E, Hajjarana H, Mohebalia M, Motevalli Haghia A. The effect of Otostegia persica in combination with chloroquine on chloroquine-sensitive and chloroquine-resistant strains of plasmodium berghei using in-vivo fixed ratios method. Iran J Pharm Res. 2012;11:583-588.
18. Ganjali A, Sotoudeh A, Jahanshahi A, Ashrafzadeh Takhtfooladi M, Bazzazan A, Roodbari N, et al. Otostegia persica extraction on healing process of burn wounds. Acta Cir Bras. 2013;28:407-411.
19. Hedayati M, Pouraboli I, Pouraboli B, Dabiri SH, Javadi A. Effects of Otostegia persica extract on serum level of glucose and morphology of pancreas in diabetic rats. Iran J Endocrinol Metab. 2010;12:435-442.
20. Bezenjani SN, Pouraboli I, Malekpour Afshar R, Mohammadi Gh. Hepatoprotective Effect of Otostegia persica Boiss. shoot extract on carbon tetrachloride-induced acute liver damage in rats. Iran J Pharm Res. 2012;11:1235-1241.
21. Hajhashemi V, Rabbani M, Asghari GR. Effect of Otostegia persica on morphine withdrawal syndrome in mice. Iran J Pharm Res. 2004;3:10-11.
22. Yoo KM, Lee CH, Lee H, Moon B, Lee CY. Relative antioxidant and cytoprotective activities of common herbs. Food Chem. 2008;106:929-936.
23. Zhang Y, Wu JH, Vickers JJ, Ong SL, Temple SE, Mori TA, et al. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension. J Hypertens. 2009;27:1609-1616.
24. Manzari-Tavakoli A, Pouraboli I, Yaghoobi MM, Mehrabani M, Mirtadzadini SM. Antihyperglycemic, antilipid peroxidation, and insulin secretory activities of Otostegia persica shoot extract in streptozotocininduced diabetic rats and in vitro C187 pancreatic β-cells. Pharm Biol. 2013;51:253-259.
25. Wolf SP. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 1994;233:182-189.
26. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-76.
27. Ong SLH, Zhang Y, Whitworth JA. Mechanisms of dexamethasone-induced hypertension. Curr Hypertens Rev. 2009;5:61-74.
28. Safaeian L, Zabolian H. Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat. ISRN Pharmacol. 2014; ID 943523.
29. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med. 2010;31:478-494.
30. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep. 2009;6:67-75.
31. Xiao HB, Jun-Fang, Lu XY, Chen XJ, Chao-Tan, Sun ZL. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level. Eur J Pharmacol. 2009;616:213-222.
32. Prahalathan P, Kumar S, Raja B. Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study. Asian Pac J Trop Biomed. 2012;2:443-448.
33. Santos MRV, Moreira FV, Fraga BP, De Sousa DP, Bonjardim LR, Quintans-Junior LJ. Cardiovascular effects of monoterpenes: a review. Rev Bras Pharmacogn. 2011;21:764-771.
34. Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005;25:311-317.